Concepedia

Ann Swift

AS

Statistics

Publications

6

Citations

511

H-Index

6

Active since

1995

Affiliations

New Frontier(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Ann Swift is an author at New Frontier specializing in molecular biology, oncology, and signal transduction.

Publications per year

1995–2015

6

Publications

6

A G Protein-coupled Receptor for UDP-glucose

Jon Chambers, Lynn E. Macdonald, Henry M. Sarau et al. · Journal of Biological Chemistry · 2000 · 343 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Molecular Cloning and Characterization of the Porcine Calcitonin Gene-Related Peptide Receptor

Nabil A. Elshourbagy, John E. Adamou, Ann Swift et al. · Endocrinology · 1998 · 48 citations

Life Sciences, Molecular Biology, Pharmacology +17

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies

Shilpa Gupta, Guillem Argilés, Pamela N. Münster et al. · Clinical Cancer Research · 2015 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

KEYNOTE-040: A phase III randomized trial of pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer.

Ezra E.W. Cohen, Jean‐Pascal Machiels, Kevin J. Harrington et al. · Journal of Clinical Oncology · 2015 · 37 citations

Medicine, Oncology, Pharmacotherapy +17

Conversion of murine Fabs isolated from a combinatorial phage display library to full length immunoglobulins

Robert S. Ames, Mark Tornetta, Keith C. Deen et al. · Journal of Immunological Methods · 1995 · 30 citations

Pharmacy, Immunology, Molecular Biology +16

1–5 of 6